HOSIER, G. W.; TOUMA, N. J. Response of renal cell carcinoma to ibrutinib, a bruton tyrosine kinase inhibitor, in a patient treated for chronic lymphocytic leukemia. Canadian Urological Association Journal, [S. l.], v. 11, n. 5, p. E237–9, 2017. DOI: 10.5489/cuaj.4316. Disponível em: https://cuaj.ca/index.php/journal/article/view/4316. Acesso em: 26 may. 2022.